ACHE and Alzheimer disease: Efforts to develop AD treatments have primarily focused on cholinergic neurotransmission, which is mediated by acetylcholine (ACh) and terminated by acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) activity.